The medical radiochemistry and biomarker development in nuclear medicine routinely performs around 25-50 radiosyntheses per week (excl. kit preparations with Tc-99m), including around 20-25 direct for use in the clinical area (PET, PET/CT, PET/MR or therapy). There is a portfolio of more than 40 radiopharmaceuticals available - with a tendency to keep on rising!
